Murray, C.; Galvan, E.; Ontiveros, C.; Deng, Y.; Bai, H.; Padron, A.S.; Hinchee-Rodriguez, K.; Garcia, M.G.; Kornepati, A.; Conejo-Garcia, J.;
et al. Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents. Int. J. Mol. Sci. 2022, 23, 5129.
https://doi.org/10.3390/ijms23095129
AMA Style
Murray C, Galvan E, Ontiveros C, Deng Y, Bai H, Padron AS, Hinchee-Rodriguez K, Garcia MG, Kornepati A, Conejo-Garcia J,
et al. Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents. International Journal of Molecular Sciences. 2022; 23(9):5129.
https://doi.org/10.3390/ijms23095129
Chicago/Turabian Style
Murray, Clare, Eva Galvan, Carlos Ontiveros, Yilun Deng, Haiyan Bai, Alvaro Souto Padron, Kathryn Hinchee-Rodriguez, Myrna G. Garcia, Anand Kornepati, Jose Conejo-Garcia,
and et al. 2022. "Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents" International Journal of Molecular Sciences 23, no. 9: 5129.
https://doi.org/10.3390/ijms23095129
APA Style
Murray, C., Galvan, E., Ontiveros, C., Deng, Y., Bai, H., Padron, A. S., Hinchee-Rodriguez, K., Garcia, M. G., Kornepati, A., Conejo-Garcia, J., & Curiel, T. J.
(2022). Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents. International Journal of Molecular Sciences, 23(9), 5129.
https://doi.org/10.3390/ijms23095129